- Forums
- ASX - By Stock
- PAR
- Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA
Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA, page-15
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Add PAR (ASX) to my watchlist
|
|||||
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M |
Open | High | Low | Value | Volume |
24.0¢ | 25.0¢ | 23.0¢ | $101.6K | 424.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 144266 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 18540 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 134266 | 0.230 |
5 | 128003 | 0.225 |
4 | 94545 | 0.220 |
2 | 60000 | 0.215 |
5 | 89516 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 18540 | 1 |
0.250 | 10000 | 1 |
0.260 | 26521 | 4 |
0.270 | 10000 | 1 |
0.275 | 16347 | 3 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |